Frailty Under-Recognized in Older Thoracic Surgery Patients

Share this content:
Frailty Under-Recognized in Older Thoracic Surgery Patients
Frailty Under-Recognized in Older Thoracic Surgery Patients

FRIDAY, Oct. 7, 2016 (HealthDay News) -- Frailty often goes unrecognized in older thoracic surgery patients, according to a study published online Oct. 6 in the Annals of Thoracic Surgery.

Angela Beckert, M.D., an assistant professor in the division of geriatrics and gerontology at the Medical College of Wisconsin in Milwaukee, and colleagues screened 125 patients for signs of frailty; their average age was 70. The patients were being assessed for major thoracic surgery such as lung resection, esophagectomy, or chest wall resection. The frailty screening checked for five traits: unintentional weight loss, grip strength, exhaustion, low activity level, and slow gait.

Exhaustion was most often found; slow gait, the least often, according to the researchers. Of the patients in the study, 68.8 percent were found to be frail or "pre-frail" -- suggesting the problem may be seriously under-recognized.

"This study indicated that a large number of patients who are candidates for major surgery have important risk factors related to frailty," study coauthor Mark Ferguson, M.D., a professor of surgery at the University of Chicago School of Medicine, said in a news release from the Society of Thoracic Surgeons. "Knowing what these factors are can help physicians, patients, and the patients' families better understand the risks and may motivate them to participate in activities that reduce their risks."

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Approves Kinase Inhibitor for Treatment of AML

FDA Approves Kinase Inhibitor for Treatment of AML

Midostaurin, in combination with chemotherapy, treats acute myeloid leukemia in adults

Enzyme Replacement Drug OK'd for Form of Batten Disease

Enzyme Replacement Drug OK'd for Form of Batten ...

Brineura will be used to treat children with late infantile neuronal ceroid lipofuscinosis type 2 Batten

is free, fast, and customized just for you!

Already a member?

Sign In Now »